Over 600,000 bottles of ramipril, a blood pressure medication, have been recalled in the U.S. due to contamination concerns. The FDA found the drug contained ingredients from an uninspected facility in India.The recall affects 2.5 mg, 5 mg, and 10 mg capsules from Lupin Pharmaceuticals,
with expiration dates up to July 2026. Patients should stop using the medication, consult their doctor, and return the product for a refund.This low-risk recall highlights broader concerns over quality control in some Indian-made drugs, following other recalls like contaminated eye drops and cancer-linked impurities in cinacalcet tablets.
